世界のウイルス分子診断市場2020年:企業別、地域別、種類・用途別

【英語タイトル】Global Viral Molecular Diagnostics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20SP05742)・商品コード:GIR20SP05742
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年9月23日(※2024年版があります。お問い合わせください)
・ページ数:100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、ウイルス分子診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。ウイルス分子診断の種類別市場規模(B型肝炎ウイルス(HBV)、C型肝炎ウイルス(HCV)、ヒト免疫不全ウイルス(HIV)、ヒトパピローマウイルス(HPV))、用途別市場規模(病院、学術機関、研究所、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Abbott Laboraories、Thermo Fisher Scientific、Roche、Bio-Rad Laboratories、Olympus、Becton, Dickinson、Qiagen、Gen-Probe
・地域別グローバル市場分析 2015年-2020年
・ウイルス分子診断の北米市場(アメリカ、カナダ、メキシコ)
・ウイルス分子診断のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・ウイルス分子診断のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・ウイルス分子診断の南米市場(ブラジル、アルゼンチン)
・ウイルス分子診断の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:B型肝炎ウイルス(HBV)、C型肝炎ウイルス(HCV)、ヒト免疫不全ウイルス(HIV)、ヒトパピローマウイルス(HPV)
・用途別分析:病院、学術機関、研究所、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The global Viral Molecular Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.9% in the forecast period of 2020 to 2025 and will expected to reach USD 10750 million by 2025, from USD 8231.6 million in 2019.

The Viral Molecular Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Viral Molecular Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Viral Molecular Diagnostics market has been segmented into:
Hepatitis B Virus (HBV)
Hepatitis C Virus (HCV)
Human Immunodeficiency Virus (HIV)
Human Papillomavirus (HPV)

By Application, Viral Molecular Diagnostics has been segmented into:
Hospitals
Academics Institutions
Laboratories
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Viral Molecular Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level Viral Molecular Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Viral Molecular Diagnostics market.

The report offers in-depth assessment of the growth and other aspects of the Viral Molecular Diagnostics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Viral Molecular Diagnostics Market Share Analysis
Viral Molecular Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Viral Molecular Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Viral Molecular Diagnostics sales, revenue and market share for each player covered in this report.

The major players covered in Viral Molecular Diagnostics are:
Abbott Laboraories
Thermo Fisher Scientific
Roche
Bio-Rad Laboratories
Olympus
Becton, Dickinson
Qiagen
Gen-Probe

【レポートの目次】

Table of Contents

1 Viral Molecular Diagnostics Market Overview
1.1 Product Overview and Scope of Viral Molecular Diagnostics
1.2 Classification of Viral Molecular Diagnostics by Type
1.2.1 Global Viral Molecular Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Viral Molecular Diagnostics Revenue Market Share by Type in 2019
1.2.3 Hepatitis B Virus (HBV)
1.2.4 Hepatitis C Virus (HCV)
1.2.5 Human Immunodeficiency Virus (HIV)
1.2.6 Human Papillomavirus (HPV)
1.3 Global Viral Molecular Diagnostics Market by Application
1.3.1 Overview: Global Viral Molecular Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Academics Institutions
1.3.4 Laboratories
1.3.5 Others
1.4 Global Viral Molecular Diagnostics Market by Regions
1.4.1 Global Viral Molecular Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Viral Molecular Diagnostics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Viral Molecular Diagnostics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Viral Molecular Diagnostics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Viral Molecular Diagnostics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Viral Molecular Diagnostics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Viral Molecular Diagnostics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboraories
2.1.1 Abbott Laboraories Details
2.1.2 Abbott Laboraories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboraories SWOT Analysis
2.1.4 Abbott Laboraories Product and Services
2.1.5 Abbott Laboraories Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Thermo Fisher Scientific SWOT Analysis
2.2.4 Thermo Fisher Scientific Product and Services
2.2.5 Thermo Fisher Scientific Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Roche SWOT Analysis
2.3.4 Roche Product and Services
2.3.5 Roche Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bio-Rad Laboratories
2.4.1 Bio-Rad Laboratories Details
2.4.2 Bio-Rad Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bio-Rad Laboratories SWOT Analysis
2.4.4 Bio-Rad Laboratories Product and Services
2.4.5 Bio-Rad Laboratories Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Olympus
2.5.1 Olympus Details
2.5.2 Olympus Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Olympus SWOT Analysis
2.5.4 Olympus Product and Services
2.5.5 Olympus Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Becton, Dickinson
2.6.1 Becton, Dickinson Details
2.6.2 Becton, Dickinson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Becton, Dickinson SWOT Analysis
2.6.4 Becton, Dickinson Product and Services
2.6.5 Becton, Dickinson Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Qiagen
2.7.1 Qiagen Details
2.7.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Qiagen SWOT Analysis
2.7.4 Qiagen Product and Services
2.7.5 Qiagen Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Gen-Probe
2.8.1 Gen-Probe Details
2.8.2 Gen-Probe Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Gen-Probe SWOT Analysis
2.8.4 Gen-Probe Product and Services
2.8.5 Gen-Probe Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Viral Molecular Diagnostics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Viral Molecular Diagnostics Players Market Share
3.2.2 Top 10 Viral Molecular Diagnostics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Viral Molecular Diagnostics Revenue and Market Share by Regions
4.2 North America Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
4.3 Europe Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
4.5 South America Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
5 North America Viral Molecular Diagnostics Revenue by Countries
5.1 North America Viral Molecular Diagnostics Revenue by Countries (2015-2020)
5.2 USA Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
5.3 Canada Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
5.4 Mexico Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
6 Europe Viral Molecular Diagnostics Revenue by Countries
6.1 Europe Viral Molecular Diagnostics Revenue by Countries (2015-2020)
6.2 Germany Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
6.3 UK Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
6.4 France Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
6.5 Russia Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
6.6 Italy Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Viral Molecular Diagnostics Revenue by Countries
7.1 Asia-Pacific Viral Molecular Diagnostics Revenue by Countries (2015-2020)
7.2 China Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
7.3 Japan Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
7.4 Korea Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
7.5 India Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
8 South America Viral Molecular Diagnostics Revenue by Countries
8.1 South America Viral Molecular Diagnostics Revenue by Countries (2015-2020)
8.2 Brazil Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
8.3 Argentina Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Viral Molecular Diagnostics by Countries
9.1 Middle East & Africa Viral Molecular Diagnostics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
9.3 UAE Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
9.4 Egypt Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
9.5 South Africa Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Viral Molecular Diagnostics Revenue and Market Share by Type (2015-2020)
10.2 Global Viral Molecular Diagnostics Market Forecast by Type (2019-2024)
10.3 Hepatitis B Virus (HBV) Revenue Growth Rate (2015-2025)
10.4 Hepatitis C Virus (HCV) Revenue Growth Rate (2015-2025)
10.5 Human Immunodeficiency Virus (HIV) Revenue Growth Rate (2015-2025)
10.6 Human Papillomavirus (HPV) Revenue Growth Rate (2015-2025)
11 Global Viral Molecular Diagnostics Market Segment by Application
11.1 Global Viral Molecular Diagnostics Revenue Market Share by Application (2015-2020)
11.2 Viral Molecular Diagnostics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Academics Institutions Revenue Growth (2015-2020)
11.5 Laboratories Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Viral Molecular Diagnostics Market Size Forecast (2021-2025)
12.1 Global Viral Molecular Diagnostics Market Size Forecast (2021-2025)
12.2 Global Viral Molecular Diagnostics Market Forecast by Regions (2021-2025)
12.3 North America Viral Molecular Diagnostics Revenue Market Forecast (2021-2025)
12.4 Europe Viral Molecular Diagnostics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Viral Molecular Diagnostics Revenue Market Forecast (2021-2025)
12.6 South America Viral Molecular Diagnostics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Viral Molecular Diagnostics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Viral Molecular Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Viral Molecular Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Viral Molecular Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Viral Molecular Diagnostics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Laboraories Corporate Information, Location and Competitors
Table 6. Abbott Laboraories Viral Molecular Diagnostics Major Business
Table 7. Abbott Laboraories Viral Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 8. Abbott Laboraories SWOT Analysis
Table 9. Abbott Laboraories Viral Molecular Diagnostics Product and Solutions
Table 10. Abbott Laboraories Viral Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 12. Thermo Fisher Scientific Viral Molecular Diagnostics Major Business
Table 13. Thermo Fisher Scientific Viral Molecular Diagnostics Total Revenue (USD Million) (2018-2019)
Table 14. Thermo Fisher Scientific SWOT Analysis
Table 15. Thermo Fisher Scientific Viral Molecular Diagnostics Product and Solutions
Table 16. Thermo Fisher Scientific Viral Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Roche Corporate Information, Location and Competitors
Table 18. Roche Viral Molecular Diagnostics Major Business
Table 19. Roche Viral Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 20. Roche SWOT Analysis
Table 21. Roche Viral Molecular Diagnostics Product and Solutions
Table 22. Roche Viral Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bio-Rad Laboratories Corporate Information, Location and Competitors
Table 24. Bio-Rad Laboratories Viral Molecular Diagnostics Major Business
Table 25. Bio-Rad Laboratories Viral Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 26. Bio-Rad Laboratories SWOT Analysis
Table 27. Bio-Rad Laboratories Viral Molecular Diagnostics Product and Solutions
Table 28. Bio-Rad Laboratories Viral Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Olympus Corporate Information, Location and Competitors
Table 30. Olympus Viral Molecular Diagnostics Major Business
Table 31. Olympus Viral Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 32. Olympus SWOT Analysis
Table 33. Olympus Viral Molecular Diagnostics Product and Solutions
Table 34. Olympus Viral Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Becton, Dickinson Corporate Information, Location and Competitors
Table 36. Becton, Dickinson Viral Molecular Diagnostics Major Business
Table 37. Becton, Dickinson Viral Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 38. Becton, Dickinson SWOT Analysis
Table 39. Becton, Dickinson Viral Molecular Diagnostics Product and Solutions
Table 40. Becton, Dickinson Viral Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Qiagen Corporate Information, Location and Competitors
Table 42. Qiagen Viral Molecular Diagnostics Major Business
Table 43. Qiagen Viral Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 44. Qiagen SWOT Analysis
Table 45. Qiagen Viral Molecular Diagnostics Product and Solutions
Table 46. Qiagen Viral Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Gen-Probe Corporate Information, Location and Competitors
Table 48. Gen-Probe Viral Molecular Diagnostics Major Business
Table 49. Gen-Probe Viral Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 50. Gen-Probe SWOT Analysis
Table 51. Gen-Probe Viral Molecular Diagnostics Product and Solutions
Table 52. Gen-Probe Viral Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Viral Molecular Diagnostics Revenue (Million USD) by Players (2015-2020)
Table 54. Global Viral Molecular Diagnostics Revenue Share by Players (2015-2020)
Table 55. Global Viral Molecular Diagnostics Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Viral Molecular Diagnostics Revenue Market Share by Regions (2015-2020)
Table 57. North America Viral Molecular Diagnostics Revenue by Countries (2015-2020)
Table 58. North America Viral Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Table 59. Europe Viral Molecular Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Viral Molecular Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Viral Molecular Diagnostics Revenue by Countries (2015-2020)
Table 62. South America Viral Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Viral Molecular Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Viral Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Table 65. Global Viral Molecular Diagnostics Revenue (Million USD) by Type (2015-2020)
Table 66. Global Viral Molecular Diagnostics Revenue Share by Type (2015-2020)
Table 67. Global Viral Molecular Diagnostics Revenue Forecast by Type (2021-2025)
Table 68. Global Viral Molecular Diagnostics Revenue by Application (2015-2020)
Table 69. Global Viral Molecular Diagnostics Revenue Share by Application (2015-2020)
Table 70. Global Viral Molecular Diagnostics Revenue Forecast by Application (2021-2025)
Table 71. Global Viral Molecular Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Viral Molecular Diagnostics Picture
Figure 2. Global Viral Molecular Diagnostics Revenue Market Share by Type in 2019
Figure 3. Hepatitis B Virus (HBV) Picture
Figure 4. Hepatitis C Virus (HCV) Picture
Figure 5. Human Immunodeficiency Virus (HIV) Picture
Figure 6. Human Papillomavirus (HPV) Picture
Figure 7. Viral Molecular Diagnostics Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Academics Institutions Picture
Figure 10. Laboratories Picture
Figure 11. Others Picture
Figure 12. Global Viral Molecular Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Viral Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Viral Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Viral Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Viral Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Viral Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Viral Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Viral Molecular Diagnostics Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Viral Molecular Diagnostics Revenue Market Share in 2019
Figure 21. Global Top 10 Players Viral Molecular Diagnostics Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Viral Molecular Diagnostics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Viral Molecular Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 25. Global Viral Molecular Diagnostics Revenue Market Share by Regions in 2018
Figure 26. North America Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 27. Europe Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 29. South America Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 31. North America Viral Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 32. North America Viral Molecular Diagnostics Revenue Market Share by Countries in 2019
Figure 33. USA Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 34. Canada Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 36. Europe Viral Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Viral Molecular Diagnostics Revenue Market Share by Countries in 2019
Figure 38. Germany Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 39. UK Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 40. France Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 41. Russia Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 42. Italy Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Viral Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Viral Molecular Diagnostics Revenue Market Share by Countries in 2019
Figure 45. China Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 46. Japan Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 47. Korea Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 48. India Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 50. South America Viral Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 51. South America Viral Molecular Diagnostics Revenue Market Share by Countries in 2019
Figure 52. Brazil Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Viral Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Viral Molecular Diagnostics Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 57. UAE Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Viral Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 60. Global Viral Molecular Diagnostics Revenue Share by Type (2015-2020)
Figure 61. Global Viral Molecular Diagnostics Revenue Share by Type in 2019
Figure 62. Global Viral Molecular Diagnostics Market Share Forecast by Type (2021-2025)
Figure 63. Global Hepatitis B Virus (HBV) Revenue Growth Rate (2015-2020)
Figure 64. Global Hepatitis C Virus (HCV) Revenue Growth Rate (2015-2020)
Figure 65. Global Human Immunodeficiency Virus (HIV) Revenue Growth Rate (2015-2020)
Figure 66. Global Human Papillomavirus (HPV) Revenue Growth Rate (2015-2020)
Figure 67. Global Viral Molecular Diagnostics Revenue Share by Application (2015-2020)
Figure 68. Global Viral Molecular Diagnostics Revenue Share by Application in 2019
Figure 69. Global Viral Molecular Diagnostics Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 71. Global Academics Institutions Revenue Growth Rate (2015-2020)
Figure 72. Global Laboratories Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Viral Molecular Diagnostics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Viral Molecular Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Viral Molecular Diagnostics Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Viral Molecular Diagnostics Revenue Market Forecast (2021-2025)
Figure 78. Europe Viral Molecular Diagnostics Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Viral Molecular Diagnostics Revenue Market Forecast (2021-2025)
Figure 80. South America Viral Molecular Diagnostics Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Viral Molecular Diagnostics Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

Abbott Laboraories、Thermo Fisher Scientific、Roche、Bio-Rad Laboratories、Olympus、Becton, Dickinson、Qiagen、Gen-Probe

★調査レポート[世界のウイルス分子診断市場2020年:企業別、地域別、種類・用途別] (コード:GIR20SP05742)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のウイルス分子診断市場2020年:企業別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆